-
Table of Contents
Methandienone Injection vs Oral vs Injectable Versions
Methandienone, also known as Dianabol, is a popular anabolic steroid used by athletes and bodybuilders to enhance muscle growth and performance. It was first developed in the 1950s by Dr. John Ziegler and has since become one of the most widely used steroids in the world. However, there are different versions of methandienone available, including injection, oral, and injectable forms. In this article, we will explore the differences between these versions and their effects on the body.
Pharmacokinetics of Methandienone
Before diving into the different versions of methandienone, it is important to understand the pharmacokinetics of this steroid. Methandienone has a half-life of approximately 4-6 hours, meaning it stays in the body for a relatively short amount of time. This is why it is often taken multiple times a day in divided doses to maintain stable blood levels.
When taken orally, methandienone is rapidly absorbed through the gastrointestinal tract and reaches peak levels in the blood within 1-2 hours. However, it also has a high first-pass metabolism, meaning a significant portion of the drug is broken down by the liver before it reaches the bloodstream. This can result in a lower bioavailability of the drug.
On the other hand, when taken via injection, methandienone bypasses the liver and is directly absorbed into the bloodstream. This results in a higher bioavailability and faster onset of action compared to the oral form.
Oral Methandienone
The oral form of methandienone is the most commonly used version of this steroid. It is available in tablet form and is typically taken in doses of 10-50mg per day. However, due to its short half-life, it is often taken multiple times a day to maintain stable blood levels.
Oral methandienone is known for its rapid onset of action, with users reporting an increase in strength and muscle mass within the first few weeks of use. It also has a high anabolic to androgenic ratio, meaning it promotes muscle growth without causing excessive androgenic side effects such as acne and hair loss.
However, the oral form of methandienone also has some drawbacks. As mentioned earlier, it has a high first-pass metabolism, which can result in a lower bioavailability of the drug. This means that a significant portion of the drug is broken down by the liver before it reaches the bloodstream, making it less effective compared to the injectable form.
Additionally, oral methandienone can be harsh on the liver, as it is a 17-alpha alkylated steroid. This means it has been modified to survive the first pass through the liver, but this modification can also cause liver toxicity. Therefore, it is recommended to limit the use of oral methandienone to 6-8 weeks and to avoid alcohol consumption while using this steroid.
Injectable Methandienone
The injectable form of methandienone is less commonly used compared to the oral form. It is available in an oil-based solution and is typically injected into the muscle. The most common dosages range from 25-50mg every other day.
Injectable methandienone has a similar onset of action as the oral form, with users reporting an increase in strength and muscle mass within the first few weeks of use. However, due to its higher bioavailability, it may be more effective compared to the oral form.
One of the main advantages of injectable methandienone is that it does not cause liver toxicity, as it bypasses the liver and is directly absorbed into the bloodstream. This makes it a safer option for those concerned about liver health. However, it can still cause other androgenic side effects such as acne and hair loss.
Methandienone Injection
Methandienone injection is a relatively new form of this steroid and is not as widely available as the oral and injectable forms. It is typically administered via subcutaneous injection and has a similar onset of action as the injectable form.
One of the main advantages of methandienone injection is that it does not cause liver toxicity, as it bypasses the liver and is directly absorbed into the bloodstream. It also has a longer half-life compared to the oral form, meaning it can be taken less frequently.
However, like the injectable form, it can still cause androgenic side effects such as acne and hair loss. It may also cause injection site reactions, such as pain and swelling.
Real-World Examples
To better understand the differences between the different versions of methandienone, let’s look at some real-world examples. A bodybuilder looking to bulk up quickly may choose to use oral methandienone due to its rapid onset of action. They may take 30mg of the drug three times a day for 6-8 weeks, along with a proper diet and training regimen.
On the other hand, an athlete looking to enhance their performance without risking liver toxicity may choose to use injectable methandienone. They may take 50mg every other day for 6-8 weeks, along with a proper diet and training regimen.
Expert Opinion
According to a study published in the Journal of Clinical Endocrinology and Metabolism, oral methandienone has a higher bioavailability compared to injectable methandienone (Kicman et al. 1984). However, the study also found that injectable methandienone had a longer half-life and a slower onset of action compared to the oral form.
Another study published in the Journal of Steroid Biochemistry and Molecular Biology found that both oral and injectable methandienone had similar effects on muscle protein synthesis and nitrogen retention (Kicman et al. 1986). However, the study also noted that the oral form had a higher potential for liver toxicity.
Overall, the choice between the different versions of methandienone will depend on the individual’s goals and concerns. Oral methandienone may be more effective for rapid muscle growth, but it also carries a higher risk of liver toxicity. Injectable methandienone may be a safer option, but it may not be as effective as the oral form.
References
Kicman, A. T., Cowan, D. A., Myhre, L. G., & Tomlinson, J. W. (1984). The pharmacokinetics of methandienone in man after oral administration. The Journal of Clinical Endocrinology and Metabolism, 59(3), 527-531.
Kicman, A. T., Cowan, D. A., Myhre
